Anti-USP22 antibody (STJA0007147)

SKU:
STJA0007147

Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Ubiquitin carboxyl-terminal hydrolase 22 is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: USP22
Gene ID: 23326
Uniprot ID: UBP22_HUMAN
Specificity: This antibody detects endogenous levels of USP22 at Human, Mouse
Immunogen: Synthesized peptide derived from human USP22
Function Histone deubiquitinating component of the transcription regulatory histone acetylation (HAT) complex SAGA. Catalyzes the deubiquitination of both histones H2A and H2B, thereby acting as a coactivator. Recruited to specific gene promoters by activators such as MYC, where it is required for transcription. Required for nuclear receptor-mediated transactivation and cell cycle progression.
Protein Name Ubiquitin Carboxyl-Terminal Hydrolase 22
Deubiquitinating Enzyme 22
Ubiquitin Thioesterase 22
Ubiquitin-Specific-Processing Protease 22
Database Links Reactome: R-HSA-3214847
Reactome: R-HSA-5689880
Cellular Localisation Nucleus
Alternative Antibody Names Anti-Ubiquitin Carboxyl-Terminal Hydrolase 22 antibody
Anti-Deubiquitinating Enzyme 22 antibody
Anti-Ubiquitin Thioesterase 22 antibody
Anti-Ubiquitin-Specific-Processing Protease 22 antibody
Anti-USP22 antibody
Anti-KIAA1063 antibody
Anti-USP3L antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance